Company
Grid Biosciences Hong Kong Limited is a biotechnology company focused on the development of prophylactic and therapeutic vaccines for Difficult-to-Treat Diseases. Grid is developing a vaccine against Epstein-Barr virus (EBV) and downstream diseases, including nasopharyngeal carcinoma, gastric cancer, infectious mononucleosis, and multiple sclerosis.
Description
Advancing Innovative Science for Conditions Caused by Difficult-to-Treat Diseases
Technology
Grid’s drug development program focuses on building next-generation technologies for effective and durable prophylactic and therapeutic vaccines.
